Ethnic-specific relationships between haemostatic and oxidative stress markers in black and white South Africans: The SABPA study

References

• Sliwa K, Wilkinson D, Hansen C, et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008;371:915–22
   PubMed Web of Science ®Google Scholar
• Connor MD, Thorogood M, Casserly B, et al. Prevalence of stroke survivors in rural South Africa: results from the Southern Africa Stroke Prevention Initiative (SASPI) Agincourt field site. Stroke 2004;35:627–32
   PubMed Web of Science ®Google Scholar
• Ogah OS, Rayner BL. Recent advances in hypertension in sub-Saharan Africa. Heart 2013;99:1390–7
   PubMed Web of Science ®Google Scholar
• Carter AM, Cymbalista CM, Spector TD, Grant PJ. Heritability of clot formation, morphology, and lysis: the EuroCLOT study. Arterioscler Thromb Vasc Biol 2007;27:2783–9
   PubMed Web of Science ®Google Scholar
• Ruef J, Peter K, Nordt TK, et al. Oxidative stress and atherosclerosis: its relationship to growth factors, thrombus formation and therapeutic approaches. Thromb Haemost 1999;82:32–7
   PubMedGoogle Scholar
• Sies H. Physiological society symposium: impaired endothelial and smooth muscle cell function in oxidative stress. Exp Physiol 1997;82:291–5
   PubMed Web of Science ®Google Scholar
• Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005;25:29–38
   PubMed Web of Science ®Google Scholar
• Blann AD, Maxwell SR, Burrows G, Miller JP. Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular disease. Atherosclerosis 1995;116:191–8
   PubMed Web of Science ®Google Scholar
• Kenet G, Freedman J, Shenkman B, et al. Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke. Arterioscler Thromb Vasc Biol 1999;19:2017–23
   PubMed Web of Science ®Google Scholar
• Lu SC. Regulation of glutathione synthesis. Mol Aspects Med 2009;30:42–59
   PubMed Web of Science ®Google Scholar
• Leopold JA, Loscalzo J. Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol 2005;25:1332–40
   PubMed Web of Science ®Google Scholar
• Yang MS, Chan HW, Yu LC. Glutathione peroxidase and glutathione reductase activities are partially responsible for determining the susceptibility of cells to oxidative stress. Toxicology 2006;226:126–30
   PubMed Web of Science ®Google Scholar
• Blankenberg S, Rupprecht HJ, Bickel C, et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. New Engl J Med 2003;349:1605–13
   PubMed Web of Science ®Google Scholar
• Jin RC, Mahoney CE, Anderson L, et al. Glutathione peroxidase-3 deficiency promotes platelet-dependent thrombosis in vivo. Circulation 2011;123:1963–73
   PubMed Web of Science ®Google Scholar
• Conlan MG, Folsom AR, Finch A, et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993;70:380–5
   PubMed Web of Science ®Google Scholar
• Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factora meta-analysis and review of the literature. Ann Intern Med 1993;118:956–63
   PubMed Web of Science ®Google Scholar
• Folsom AR, Wu KK, Conlan MG, et al. Distributions of hemostatic variables in blacks and whites: population reference values from the Atherosclerosis Risk in Communities (ARIC) Study. Ethn Dis 1992;2:35–46
   PubMedGoogle Scholar
• Lutsey PL, Cushman M, Steffen LM, et al. Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. J Thromb Haemost 2006;4:2629–35
   PubMed Web of Science ®Google Scholar
• Greyling A, Pieters M, Hoekstra T, et al. Differences in the association of PAI-1 activity with the metabolic syndrome between African and Caucasian women. Nutr Metab Cardiovasc Dis 2007;17:499–507
   PubMed Web of Science ®Google Scholar
• Lacy F, Kailasam MT, O'Connor DT, et al. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 2000;36:878–84
   PubMed Web of Science ®Google Scholar
• Vischer UM. von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost 2006;4:1186–93
   PubMed Web of Science ®Google Scholar
• Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003;89:601–9
   PubMed Web of Science ®Google Scholar
• Taverne YJHJ, Bogers AJJC, Duncker DJ, Merkus D. Reactive oxygen species and the cardiovascular system. Oxid Med Cell Longev 2013;2013:862423
   PubMed Web of Science ®Google Scholar
• Kruger R, Schutte R, Huisman H, et al. Associations between reactive oxygen species, blood pressure and arterial stiffness in black South Africans: the SABPA study. J Hum Hypertens 2012;26:91–7
   PubMed Web of Science ®Google Scholar
• Lammertyn L, Schutte AE, Pieters M, Schutte R. D-dimer relates positively with increased blood pressure in black South Africans: The SABPA study. Thromb Res 2014;133:1152–7
   PubMed Web of Science ®Google Scholar
• Ibrahim H, El-Meligi A, Abdel-Hamid M, Elhendy A. Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus. Med Sci Monit 2004;10:CR85–9
   PubMed Web of Science ®Google Scholar
• Marfell-Jones M, Olds T, Stewart A, Carter L. International standards for anthropometric assessment. Sydney, Australia: International Society for the Advancement of Kinanthropometry; 2006
   Google Scholar
• Norton KI, Olds T, Commission AS. Anthropometrica: a textbook of body measurement for sports and health courses. Sydney, Australia: University of New South Wales Press; 1996
   Google Scholar
• Lisman T, de Groot PG, Meijers JC, Rosendaal FR. Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood 2005;105:1102–5
   PubMed Web of Science ®Google Scholar
• Hayashi I, Morishita Y, Imai K, et al. High-throughput spectrophotometric assay of reactive oxygen species in serum. Mutat Res 2007;631:55–61
   PubMed Web of Science ®Google Scholar
• Harris MT, Davis WW, Le N-A, et al. Free oxygen radicals in whole blood correlate strongly with high-sensitivity C-reactive protein. J Clin Lipidol 2007;1:593–8
   PubMed Web of Science ®Google Scholar
• Gill R, Tsung A, Billiar T. Linking oxidative stress to inflammation: Toll-like receptors. Free Radic Biol Med 2010;48:1121–32
   PubMed Web of Science ®Google Scholar
• Levi M, van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005;15:254–9
   PubMed Web of Science ®Google Scholar
• Martina V, Bruno GA, Pannocchia A, et al. PAI-1 reduction after treatment with glutathione in NIDDM. Fibrinolysis 1996;10:63–5
   Google Scholar
• Rybka J, Kupczyk D, Kędziora-Kornatowska K, et al. Glutathione-related antioxidant defense system in elderly patients treated for hypertension. Cardiovasc Toxicol 2011;11:1–9
   PubMed Web of Science ®Google Scholar
• Wu G, Fang YZ, Yang S, et al. Glutathione metabolism and its implications for health. J Nutr 2004;134:489–92
   PubMed Web of Science ®Google Scholar
• Shacter E, Williams JA, Levine RL. Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. Free Radic Biol Med 1995;18:815–21
   PubMed Web of Science ®Google Scholar
• Rosenfeld MA, Shegolihin AN, Bychkova AV, et al. Oxidative modification of fibrinogen molecules. Dokl Biochem Biophys 2013;452:255–8
   PubMed Web of Science ®Google Scholar
• Kaptoge S, White I, Thompson S, et al. Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration. Am J Epidemiol 2007;166:867–79
   PubMed Web of Science ®Google Scholar
• Shacter E, Williams JA, Lim M, Levine RL. Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay. Free Radic Biol Med 1994;17:429–37
   PubMed Web of Science ®Google Scholar
• Azizova OA, Aseichev AV, Piryazev AP, et al. Effects of oxidized fibrinogen on the functions of blood cells, blood clotting, and rheology. Bull Exp Biol Med 2007;144:397–407
   PubMed Web of Science ®Google Scholar
• Vadseth C, Souza JM, Thomson L, et al. Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. J Biol Chem 2004;279:8820–6
   PubMed Web of Science ®Google Scholar
• Upchurch Jr GR, Ramdev N, Walsh MT, Loscalzo J. Prothrombotic consequences of the oxidation of fibrinogen and their inhibition by aspirin. J Thromb Thrombolysis 1998;5:9–14
   PubMed Web of Science ®Google Scholar
• Tetik S, Kaya K, Yardimci T. Effect of oxidized fibrinogen on hemostatic system: in vitro study. Clin Appl Thromb Hemost 2011;17:259–63
   PubMed Web of Science ®Google Scholar
• Martinez M, Weisel JW, Ischiropoulos H. Functional impact of oxidative posttranslational modifications on fibrinogen and fibrin clots. Free Radic Biol Med 2013;65:411–8
   PubMed Web of Science ®Google Scholar
• Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Normal reference laboratory values. New Engl J Med 2004;351:1548–63
   PubMed Web of Science ®Google Scholar